| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.40▼ | 1.41▼ | 1.42▼ | 1.39▼ | 1.33▲ |
| MA10 | 1.41▼ | 1.42▼ | 1.41▼ | 1.37▲ | 1.45▼ |
| MA20 | 1.41▼ | 1.40▼ | 1.39▲ | 1.35▲ | 1.56▼ |
| MA50 | 1.40▼ | 1.38▲ | 1.38▲ | 1.47▼ | 1.45▼ |
| MA100 | 1.39▲ | 1.36▲ | 1.35▲ | 1.56▼ | 3.33▼ |
| MA200 | 1.38▲ | 1.38▲ | 1.43▼ | 1.49▼ | 5.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.001▼ | 0.001▲ | 0.017▲ | -0.024▼ |
| RSI | 42.787▼ | 51.325▲ | 51.919▲ | 48.646▼ | 44.601▼ |
| STOCH | 12.500▼ | 35.931 | 61.153 | 36.682 | 23.388 |
| WILL %R | -75.000▼ | -63.158 | -63.158 | -60.109 | -73.954 |
| CCI | -148.287▼ | -26.090 | -11.734 | 58.820 | -83.984 |
|
Monday, November 17, 2025 07:17 AM
The targeted radiotherapies for cancer market is experiencing significant growth, driven by advancements in technology and investment. The cancer radiotherapy market, particularly the radioligand ...
|
|
Sunday, November 16, 2025 11:36 PM
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet To view an enhanced version of this graphic, please visit: ...
|
|
Friday, November 14, 2025 01:02 PM
NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.1 million in its third quarter. On a per-share basis, the New York-based company said it had a loss ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 1.44 | 1.44 | 1.38 | 1.38 | 57,994 |
| 26/11/25 | 1.38 | 1.48 | 1.372 | 1.45 | 94,400 |
| 25/11/25 | 1.38 | 1.40 | 1.32 | 1.40 | 53,500 |
| 24/11/25 | 1.31 | 1.42 | 1.30 | 1.37 | 101,100 |
| 21/11/25 | 1.28 | 1.34 | 1.25 | 1.33 | 116,900 |
| 20/11/25 | 1.35 | 1.41 | 1.29 | 1.29 | 168,300 |
| 19/11/25 | 1.44 | 1.44 | 1.33 | 1.36 | 123,200 |
| 18/11/25 | 1.46 | 1.48 | 1.38 | 1.43 | 177,317 |
| 17/11/25 | 1.38 | 1.60 | 1.35 | 1.45 | 1,619,400 |
| 14/11/25 | 1.24 | 1.34 | 1.235 | 1.27 | 63,000 |
|
|
||||
|
|
||||
|
|